CSIMarket


Spectrum Pharmaceuticals Inc   (SPPI)
Other Ticker:  
 


 

Spectrum Pharmaceuticals Inc

SPPI's Financial Statements and Analysis



Spectrum Pharmaceuticals Inc narrowed first quarter of 2023 net loss per share of $-0.02 compare to net loss per share of $-0.09 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.04 realized in previous quarter.


first quarter of 2023
Earnings Per Share Revenues
$ -0.02 $  16 Mill
$+0.07     $+16M    



Spectrum Pharmaceuticals Inc 's Revenue rose by 0 % in first quarter of 2023 (Mar 31 2023) year on year, to $16 million and advanced by 54.39 % sequentially.


Spectrum Pharmaceuticals Inc is Expected to report next financial results on March 30, 2024.

More on SPPI's Income Statement



Spectrum Pharmaceuticals Inc 's in thefirst quarter of 2023 recorded net loss of $-5.007 million, an improvement compare to net loss of $-15.442 million in I. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-8.986 million realized in previous quarter.

More on SPPI's Growth

Spectrum Pharmaceuticals Inc Inventories
SPPI's Cash flow In the first quarter of 2023 company's net cash flow was $12 million, capital expenditures fell by -0.039176.92%, to $0 millions compare to same quarter a year ago

More on SPPI's Cash flow Statement


Spectrum Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Spectrum Pharmaceuticals Inc payed $ -0.44 cash per share, on a free-cash flow basis .

Book value fell by -12.46 % sequentially to $0.13 per share, -5.41% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.13 per share from $ 0.15.

Company issued 18.01 million shares or 9.79 % in Mar 31 2023.


More on SPPI's Dividends

 Market Capitalization (Millions) 208
 Shares Outstanding (Millions) 202
 Total Debt (Millions $) 29
 Revenue (TTM) (Millions $) 26
 Net Income (TTM) (Millions $) -65
 Cash Flow (TTM) (Millions $) -26
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1




Spectrum Pharmaceuticals Inc does not pay out common stock dividend.

In trailing twelve-month period Spectrum Pharmaceuticals Inc had negative $ -0.44 cash flow per share, on a free-cash flow basis .

Book value fell by -12.46 % sequentially to $0.13 per share, -5.41% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.13 per share from $ 0.15.

Company issued 18.01 million shares or 9.79 % in Mar 31 2023.


More on SPPI's Balance Sheets

 Market Capitalization (Millions) 208
 Shares Outstanding (Millions) 202
 Total Debt (Millions $) 29
 Revenue (TTM) (Millions $) 26
 Net Income (TTM) (Millions $) -65
 Cash Flow (TTM) (Millions $) -26
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 1
   


  News about Spectrum Pharmaceuticals Inc Earnings

Spectrum Pharmaceuticals Inc Reports Q1 2023 Revenue of $15.615 Million amidst Concerns over Growing Net Loss

As investors eagerly await Spectrum Pharmaceuticals Inc's latest financial data, the recent announcement of their Q1 2023 revenue of...


Date modified: 2023-05-14T14:33:54+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com